COMPANY

HelixBind

HQ: Boxborough, MA source · helixbind.com ↗ · New England

Keywords: diagnostics Bacteremia antimicrobial resistance endocarditis lyme disease Candidemia

Location: Boxborough, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)42NIH grants

Funding and NIH signals

NIH award NIH awarded $1M (SBIR Phase II 2R44AI157322-04A1, competing renewal, notice Aug 6, 2026); 5 NIH awards totaling $5.04M in the last 12 months. NIH RePORTER 2R44AI157322-04A1 (Aug 6, 2026)
Evidence (5 events)
- Aug 6, 2026 · NIH RePORTER 2R44AI157322-04A1
  Organization: HELIXBIND, INC.; City/State: Boxborough, MA; Project number: 2R44AI157322-04A1; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-06; FY total cost (award amount): 1000000; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Direct-from-specimen characterization of bloodstream infections; Organization type: Domestic For-Profits
- Jul 16, 2026 · NIH RePORTER 1R44AI197309-01
  Organization: HELIXBIND, INC.; City/State: Boxborough, MA; Project number: 1R44AI197309-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-16; FY total cost (award amount): 1029859; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Automated system for the direct from blood characterization of bloodstream infections; Organization type: Domestic For-Profits
- Jun 30, 2026 · NIH RePORTER 5R44AI186712-03
  Organization: HELIXBIND, INC.; City/State: Boxborough, MA; Project number: 5R44AI186712-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-30; FY total cost (award amount): 1019702; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: An automated culture-free system for the identification of bloodstream infections direct from blood; Organization type: Domestic For-Profits
- Jun 19, 2026 · NIH RePORTER 5R44AI136064-07
  Organization: HELIXBIND, INC.; City/State: Boxborough, MA; Project number: 5R44AI136064-07; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-19; FY total cost (award amount): 986903; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Direct-from-specimen identification of pathogens common in endocarditis; Organization type: Domestic For-Profits
- May 27, 2026 · NIH RePORTER 5SB1AI183963-03
  Organization: HELIXBIND, INC.; City/State: Boxborough, MA; Project number: 5SB1AI183963-03; Activity code: SB1; Fiscal year: 2026; Award notice date: 2026-05-27; FY total cost (award amount): 1000000; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Commercialization Readiness Pilot (CRP) program support for: Ultra-sensitive, direct-from-blood, molecular detection of Borrelia infections.; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Aug 6, 2026 Grant Government grant — SBIR: $1M (annual award, as published), announced Aug 6, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jul 16, 2026 Grant Government grant — SBIR: $1.03M (annual award, as published), announced Jul 16, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 30, 2026 Grant Government grant — SBIR: $1.02M (annual award, as published), announced Jun 30, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 19, 2026 Grant Government grant — SBIR: $986,903 (annual award, as published), announced Jun 19, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
May 27, 2026 Grant Government grant — SBIR: $1M (annual award, as published), announced May 27, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jul 2, 2025 Grant Government grant — SBIR: $1.03M (annual award, as published), announced Jul 2, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 13, 2025 Grant Government grant — SBIR: $996,497 (annual award, as published), announced Jun 13, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 11, 2025 Grant Government grant — SBIR: $1M (annual award, as published), announced Jun 11, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Apr 30, 2025 Grant Government grant — SBIR: $1M (annual award, as published), announced Apr 30, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Dec 12, 2024 Grant Government grant — SBIR: $1.05M (annual award, as published), announced Dec 12, 2024. Agency: NIH/NIAID. Source: government award database. source ↗
Oct 1, 2019 Trial start —: Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood source ↗

Funding

Last 2 years.

Aug 6, 2026 Government grant — SBIR: $1M (annual award, as published), announced Aug 6, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jul 16, 2026 Government grant — SBIR: $1.03M (annual award, as published), announced Jul 16, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 30, 2026 Government grant — SBIR: $1.02M (annual award, as published), announced Jun 30, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 19, 2026 Government grant — SBIR: $986,903 (annual award, as published), announced Jun 19, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
May 27, 2026 Government grant — SBIR: $1M (annual award, as published), announced May 27, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jul 2, 2025 Government grant — SBIR: $1.03M (annual award, as published), announced Jul 2, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 13, 2025 Government grant — SBIR: $996,497 (annual award, as published), announced Jun 13, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 11, 2025 Government grant — SBIR: $1M (annual award, as published), announced Jun 11, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Apr 30, 2025 Government grant — SBIR: $1M (annual award, as published), announced Apr 30, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Dec 12, 2024 Government grant — SBIR: $1.05M (annual award, as published), announced Dec 12, 2024. Agency: NIH/NIAID. Source: government award database. source ↗

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT04147975	Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood	Not listed	Unknown status (ClinicalTrials.gov)	Oct 1, 2019	Sep 30, 2020 (estimated)

NIH awards 42

Annual award amounts. Total $37.9M.

Jul 26, 2024 NIH award 5R44AI165300-03 FY2024: $995,893 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Direct from blood identification of bloodstream in source ↗
Jul 24, 2024 NIH award 5R44AI172441-03 FY2024: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Direct detection and identification of antimicro source ↗
Jul 8, 2024 NIH award 1R44AI186712-01 FY2024: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. An automated culture-free system for the identif source ↗
May 31, 2024 NIH award 5R44AI174578-02 FY2024: $985,142 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Diagnostic tool for assessment and tracking of mic source ↗
May 23, 2024 NIH award 5SB1AI172440-02 FY2024: $997,234 awarded for that fiscal year; activity SB1 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Commercialization Readiness Pilot (CRP) program su source ↗
Apr 2, 2024 NIH award 1SB1AI183963-01 FY2024: $1,000,000 awarded for that fiscal year; activity SB1 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Commercialization Readiness Pilot (CRP) program source ↗
Mar 1, 2024 NIH award 5SB1AI172427-03 FY2024: $1,000,000 awarded for that fiscal year; activity SB1 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Commercialization Readiness Pilot (CRP) program source ↗
Jan 19, 2024 NIH award 2R44AI136064-05A1 FY2024: $1,001,029 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Direct-from-specimen identification of pathoge source ↗
Aug 3, 2023 NIH award 5R44AI172441-02 FY2023: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Direct detection and identification of antimicro source ↗
Jul 7, 2023 NIH award 5R44AI165300-02 FY2023: $991,282 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Direct from blood identification of bloodstream in source ↗
Jun 23, 2023 NIH award 1R44AI174578-01 FY2023: $1,050,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Diagnostic tool for assessment and tracking of m source ↗
Jun 20, 2023 NIH award 1SB1AI172440-01A1 FY2023: $1,000,000 awarded for that fiscal year; activity SB1 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Commercialization Readiness Pilot (CRP) progra source ↗
Mar 28, 2023 NIH award 5R44AI124726-06 FY2023: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. An Integrated Device for Rapid Bacteremia Diagno source ↗
Mar 13, 2023 NIH award 5R44AI157322-03 FY2023: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Massively Multiplexed dsDNA Invasion Arrays source ↗
Feb 24, 2023 NIH award 5SB1AI172427-02 FY2023: $1,000,000 awarded for that fiscal year; activity SB1 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Commercialization Readiness Pilot (CRP) program source ↗
Aug 9, 2022 NIH award 1R44AI172441-01 FY2022: $1,050,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Direct detection and identification of antimicro source ↗
Aug 1, 2022 NIH award 1R44AI165300-01A1 FY2022: $994,610 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Direct from blood identification of bloodstream source ↗
May 16, 2022 NIH award 5R44AI152628-03 FY2022: $980,611 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Development of an automated IVD for the ultra-sens source ↗
Apr 1, 2022 NIH award 5R44AI157322-02 FY2022: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Massively Multiplexed dsDNA Invasion Arrays source ↗
Mar 29, 2022 NIH award 5R44AI109913-06 FY2022: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. A Culture-Free Platform for Rapid Fungal Pathoge source ↗
Mar 29, 2022 NIH award 5R44AI124726-05 FY2022: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. An Integrated Device for Rapid Bacteremia Diagno source ↗
Mar 3, 2022 NIH award 1SB1AI172427-01 FY2022: $1,000,000 awarded for that fiscal year; activity SB1 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Commercialization Readiness Pilot (CRP) program source ↗
May 12, 2021 NIH award 5R44AI152628-02 FY2021: $992,384 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Development of an automated IVD for the ultra-sens source ↗
Apr 14, 2021 NIH award 1R44AI157322-01 FY2021: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Massively Multiplexed dsDNA Invasion Arrays source ↗
Mar 26, 2021 NIH award 2R44AI124726-04 FY2021: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. An Integrated Device for Rapid Bacteremia Diagno source ↗
Mar 18, 2021 NIH award 5R44AI109913-05 FY2021: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. A Culture-Free Platform for Rapid Fungal Pathoge source ↗
Dec 17, 2020 NIH award 5R44AI136064-04 FY2021: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. An automated platform for direct-from-specimen i source ↗
Jun 15, 2020 NIH award 1R44AI152628-01A1 FY2020: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. Development of an automated IVD for the ultra- source ↗
Apr 16, 2020 NIH award 2R44AI109913-04 FY2020: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. A Culture-Free Platform for Rapid Fungal Pathoge source ↗
Jan 3, 2020 NIH award 5R44AI136064-03 FY2020: $998,005 awarded for that fiscal year; activity R44 (SBIR); PI SINGER, ALON; recipient as written: HELIXBIND, INC., Boxborough, MA. An automated platform for direct-from-specimen ide source ↗